StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Earnings

Mirum Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$185.70M
+39.6% on a year earlier
EPS, Q3 FY2026
-$0.87
$0.05 a year earlier
Latest guidance
Raised
Nov 3, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Mirum Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026after the close$185.70M+39.6%-$0.87Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$176.20M+37.9%–Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$159.90M+43.3%–Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$148.93M+49.8%-$0.47Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025after the close$133.00M–$0.05Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025after the close$127.80M+64.1%-$0.12Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$111.60M+61.3%–Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025after the close$99.41M+42.9%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$77.88M+107.7%-$0.52Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$69.20M–-$0.54Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Mirum Pharmaceuticals's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net product salesFY2026$715.00M – $720.00M$630.00M – $650.00MRaisedNov 3, 2026
net product sales guidanceFY2026$680.00M – $700.00M$660.00M – $680.00MRaisedAug 5, 2026

Guidance vs results

The last range Mirum Pharmaceuticals gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$500.00M – $510.00M$521.33MΣ4QAbove range
Q1 FY2022Revenue$8.00M$12.90MAbove range

Guidance history

Every forecast Mirum Pharmaceuticals put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026net product salesFY2026$715.00M – $720.00MRaised
Aug 5, 2026net product sales guidanceFY2026$680.00M – $700.00MRaised
May 6, 2026net product salesFY2026$660.00M – $680.00MRaised
Feb 25, 2026global net product salesFY2026$630.00M – $650.00MNew
Jan 12, 2026global net product salesFY2026$630.00M – $650.00MNew
Nov 4, 2025revenue guidanceFY2025$500.00M – $510.00MNew
Aug 6, 2025revenue guidanceFY2025$490.00M – $510.00MRaised
May 7, 2025revenueFY2025$435.00M – $450.00MRaised
Feb 26, 2025global net product salesFY2025$420.00M – $435.00MReaffirmed
Jan 13, 2025global net product salesFY2025$420.00M – $435.00MNew
Nov 12, 2024guidanceFY2024$330.00M – $335.00MRaised
Aug 7, 2024global net product salesFY2024$310.00M – $320.00MReaffirmed
May 8, 2024total revenueFY2024$310.00M – $320.00MReaffirmed
Feb 28, 2024global net product salesFY2024$310.00M – $320.00MNew
Aug 3, 2023US net product sales growthFY2023+50%Reaffirmed
Mar 8, 2023net product sales growthFY2023+50%New
Nov 9, 2022net product salesFY2022$70.00MNew
Mar 9, 2022LIVMARLI net product salesQ1 FY2022$8.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Mirum Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. News
  5. Results
  6. Results
  7. Update
  8. Results
  9. Results
  10. Update
  11. Update
  12. Update
  13. Results
  14. Results
  15. Results

See a number that looks wrong?